Reproducibility Study of OABSS and Its Response to Treatment
NCT02667470
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Overactive Bladder
Interventions
DRUG:
Solifenacin
Sponsor
Astellas Pharma Inc